| abstract |
The present invention relates to compounds of the Formula (I), the pharmaceutically acceptable salts and stereoisomers thereof, which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions in mammals. In said Formula (I), : n is an integer, preferably n is 1; R1 and R2 are independently selected from the group consisting of (a), (b), (c), (d), (e), (f), (g), (h), (i) and (j). |